📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
161 analysed today
FollowTelegram
161
Today
149,562
All-time analysed
42,894
Positive
6,654
Negative
91,341
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
52 announcements match the current filters (relevance ≥ 5).
Dabur Clarifies USFDA Observations at Silvassa Plant; Cites Insignificant Revenue Impact
Dabur India has addressed media reports regarding USFDA observations at its Silvassa manufacturing facility, clarifying that the issues pertain to a minor section of the plant. The company stated that the affected portion contributes an insignificant amount to total revenue and the facility remains fully operational. A corrective and preventive action plan has already been submitted to the USFDA, with regular progress updates being shared. Management maintains that there is currently no material impact on the company's financial or operational performance.
Key Highlights
USFDA observations are limited to a small section of the Silvassa plant in Dadra and Nagar Haveli
The company confirms the affected area generates insignificant revenue for the overall business
The manufacturing plant continues to be operational despite the regulatory findings
A robust corrective and preventive action plan has been shared with the USFDA to resolve concerns
Management asserts no immediate impact on financial or operational activities as of June 1, 2026
👀 What to Watch
Investors should monitor for further updates from the USFDA regarding the acceptance of the corrective plan. While the immediate financial impact is low, data integrity issues are sensitive and require successful resolution to avoid broader regulatory risks.
Dabur India Incorporates New Step-Down Subsidiary 'Pravaah Consumer Group' in Delaware, USA
Dabur India Limited has announced the incorporation of a new step-down wholly owned subsidiary, Pravaah Consumer Group Inc., in Delaware, USA. The entity was incorporated on May 15, 2026, through Dabur International Limited, which is a wholly owned subsidiary of the parent company. This move follows a prior intimation dated May 6, 2026, regarding the proposed expansion. The establishment of a dedicated US entity suggests a strategic focus on scaling operations or distribution within the North American consumer market.
Key Highlights
Incorporation of 'PRAVAAH CONSUMER GROUP INC.' in Delaware, USA, effective May 15, 2026
The new entity is a 100% wholly owned subsidiary of Dabur International Limited
Follows through on the strategic proposal initially disclosed on May 6, 2026
Formal confirmation of incorporation was received by the company on May 18, 2026
👀 What to Watch
Investors should monitor for future disclosures regarding the specific business activities and capital expenditure planned for this new US-based entity. This expansion signals long-term intent to grow international revenue contributions.
Dabur Q4 FY26: Domestic FMCG Revenue Up 9.5%, PAT Rises 15% with 6% Volume Growth
Dabur India reported a resilient Q4 FY26 with consolidated revenue growth of 7.3% and a 15% increase in PAT. The domestic FMCG business outperformed with a 9.5% revenue growth, driven by a healthy 6% volume expansion and a strong 17% surge in the Home & Personal Care (HPC) segment. While international business remained muted at 2.5% growth due to geopolitical tensions in the Middle East, rural demand continued to outpace urban markets. To counter a projected 10% inflation in raw materials, the company has initiated a 4% price hike across its portfolio.
Key Highlights
Domestic FMCG business grew 9.5% with 6% volume growth; HPC segment led with 17% growth.
Hair Care and Home Care portfolios delivered robust growth of 28% and 24% respectively.
Consolidated PAT increased by 15% YoY, while operating profit grew by 8.2%.
Management announced a 4% price hike to mitigate a 10% inflationary impact on input costs.
International business growth was restricted to 2.5% in INR terms due to West Asia geopolitical headwinds.
👀 What to Watch
Investors should focus on Dabur's ability to maintain volume growth following the 4% price hike and monitor the recovery of the international segment. The company remains a strong beneficiary of the rural demand recovery and the structural shift toward herbal products.
Dabur India Sets July 17 as Record Date for ₹5.50 Final Dividend
Dabur India Limited has fixed July 17, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹5.50 per share (550%) for FY 2025-26. The dividend is subject to approval at the Annual General Meeting (AGM) scheduled for August 06, 2026. If approved, the company plans to dispatch the dividend payments on or before September 04, 2026. The book closure period is set from July 20 to July 24, 2026.
Key Highlights
Final dividend recommended at ₹5.50 per equity share (550%) for FY 2025-26
Record date for dividend eligibility is fixed as July 17, 2026
Annual General Meeting (AGM) to be held on August 06, 2026, for shareholder approval
Dividend payment to be completed on or before September 04, 2026
Book closure period scheduled from July 20, 2026, to July 24, 2026
👀 What to Watch
Investors interested in the dividend payout should ensure they hold the stock before the ex-dividend date, typically one working day prior to the July 17 record date.
Dabur India Announces Record Date for Final Dividend of Rs 5.50 per Share
Dabur India Limited has recommended a final dividend of Rs 5.50 per equity share, representing a 550% payout for the financial year 2025-26. The company has officially fixed July 17, 2026, as the record date to identify eligible shareholders for this payout. The dividend is subject to approval by shareholders at the upcoming Annual General Meeting scheduled for August 06, 2026. Upon approval, the company intends to complete the dividend disbursement on or before September 04, 2026.
Key Highlights
Final dividend of Rs 5.50 per share (550%) recommended for FY 2025-26
Record date for dividend eligibility fixed as July 17, 2026
Book closure period set from July 20, 2026, to July 24, 2026
Dividend payment to be completed by September 04, 2026, post-AGM approval
👀 What to Watch
Investors seeking to benefit from the dividend should ensure they hold the shares before the ex-dividend date, which typically precedes the July 17 record date. This consistent payout underscores the company's stable cash flow and commitment to shareholder returns.
Dabur Re-appoints Rajiv Mehrishi for 5 Years; Reduces Mukesh Butani's Tenure to 1 Year
Dabur India's board has approved the re-appointment of former CAG Rajiv Mehrishi as an Independent Director for a second five-year term starting September 2026. In a notable change, the tenure of Independent Director Mukesh Hari Butani has been shortened from five years to just one year, ending December 2026, due to his other professional commitments. Additionally, Vice Chairman Saket Burman is set for re-appointment as he retires by rotation. These leadership decisions, subject to shareholder approval at the 51st AGM, aim to maintain governance stability while accommodating individual director availability.
Key Highlights
Mr. Rajiv Mehrishi re-appointed as Independent Director for a 5-year term from Sept 1, 2026, to Aug 31, 2031.
Mr. Mukesh Hari Butani's second term tenure reduced from 5 years to 1 year, now ending Dec 31, 2026.
Mr. Saket Burman, Vice Chairman and promoter, proposed for re-appointment as Non-Executive Director.
All board recommendations are subject to shareholder approval at the upcoming 51st Annual General Meeting.
The changes reflect a mix of long-term governance continuity and individual director rationalization of commitments.
👀 What to Watch
These are routine governance and board composition updates. Investors should monitor the upcoming AGM voting results but no immediate portfolio action is required.
Dabur Re-appoints Rajiv Mehrishi and Saket Burman; Modifies Mukesh Butani's Tenure
Dabur India has approved the re-appointment of Mr. Rajiv Mehrishi as a Non-Executive Independent Director for a second five-year term effective September 1, 2026. The company also recommended the re-appointment of Vice Chairman Mr. Saket Burman as a Non-Executive Director. Notably, the tenure of Independent Director Mr. Mukesh Hari Butani has been reduced from five years to one year, ending December 31, 2026, at his own request to manage other professional commitments. These board changes are subject to shareholder approval at the upcoming 51st Annual General Meeting on August 6, 2026.
Key Highlights
Mr. Rajiv Mehrishi re-appointed as Independent Director for a 5-year term from September 2026 to August 2031.
Mr. Mukesh Hari Butani's second term tenure reduced from 5 years to 1 year, now ending December 31, 2026.
Mr. Saket Burman, a promoter and current Vice Chairman, recommended for re-appointment as Non-Executive Director.
All management changes are subject to shareholder approval at the 51st AGM scheduled for August 6, 2026.
👀 What to Watch
These are routine board rotations and re-appointments of experienced members which ensure continuity in governance. Investors should view this as a standard regulatory filing with no immediate impact on the company's operational fundamentals.
Dabur Recommends Final Dividend of Rs 5.50 Per Share for FY 2025-26
Dabur India Limited has recommended a final dividend of Rs. 5.50 per equity share for the financial year 2025-26, representing a 550% payout on its Re. 1 face value. The dividend is subject to shareholder approval at the 51st Annual General Meeting scheduled for August 06, 2026. Alongside the dividend, the company approved its audited financial results for the year ended March 31, 2026, with an unmodified auditor's opinion. The group also reported a minor share of net loss amounting to Rs. 1.80 crores from its joint venture operations.
Key Highlights
Final dividend of Rs. 5.50 per equity share recommended for FY 2025-26
Dividend payout represents 550% of the face value of Re. 1 per share
51st Annual General Meeting (AGM) scheduled for August 06, 2026
Group share of net loss from joint venture reported at Rs. 1.80 crores for the year
👀 What to Watch
Investors should monitor for the announcement of the record date to ensure eligibility for the dividend payout. The recommendation reflects stable cash flows, making it a positive signal for long-term income-seeking shareholders.
Dabur Q4 Net Profit Surges 16% to Rs 362 Cr; Revenue Up 7.3%; Final Dividend of Rs 5.50
Dabur India reported a strong Q4 FY26 performance with consolidated net profit rising 16% YoY to Rs 362 crore and revenue growing 7.3% to Rs 3,038 crore. The domestic FMCG business saw a robust 9.5% growth, supported by a 6% volume increase and rural demand outpacing urban growth by 350bps. Key categories like Hair Care and Home Care grew significantly at 27% and 24% respectively, while Quick Commerce channels surged by 54%. The company also declared a final dividend of Rs 5.50 per share, bringing the total dividend for FY26 to 825%.
Key Highlights
Consolidated Net Profit grew 16% YoY to Rs 362 Cr; Revenue increased 7.3% to Rs 3,038 Cr
India FMCG volume growth stood at 6%, with rural demand outperforming urban by 350bps
E-commerce and Quick Commerce channels showed stellar growth of 49% and 54% respectively
Market share gains across 95% of the portfolio, including a 233bps gain in the Digestives segment
Board recommended a final dividend of Rs 5.50 per share, totaling Rs 975.50 crore for the final payout
👀 What to Watch
Investors should view this as a strong performance, especially given the healthy volume growth and rural recovery. The significant gains in market share and traction in high-growth digital channels make Dabur a solid long-term hold in the FMCG sector.
Dabur Q4 FY26 Results: PAT Up 15.1% to ₹368.6 Cr, Revenue Grows 7.3% with 6% Volume Growth
Dabur India Limited reported a steady Q4 FY26 with consolidated revenue growing 7.3% YoY to ₹3,038 crore, supported by a 6% volume growth in the domestic FMCG business. Net profit increased by 15.1% to ₹368.6 crore, while operating margins saw a slight expansion of 12 bps. The company faced headwinds from unseasonal rains affecting summer products and geopolitical issues in the MENA region, but saw strong double-digit growth in its Home & Personal Care segment. A total dividend of ₹8.25 per share was declared for the fiscal year.
Key Highlights
Consolidated Revenue reached ₹3,038 Cr, up 7.3% YoY, with domestic FMCG volume growth at 6%.
Reported Net Profit grew 15.1% YoY to ₹368.6 Cr, with PAT margins expanding by 80 bps to 12.1%.
Home & Personal Care (HPC) segment performed strongly with Hair Care and Home Care both growing in the mid-twenties.
International business grew 2.5% in INR terms, despite a 6.1% constant currency decline in the MENA region due to geopolitical volatility.
Total dividend for FY26 stands at ₹8.25 per share, representing an 825% payout on face value.
👀 What to Watch
Investors should take confidence in the 6% volume growth and significant margin expansion despite external headwinds like unseasonal rains and geopolitical tension. The stock remains a strong defensive play with consistent dividend payouts and market share gains in core categories.
Dabur India Recommends ₹5.50 Final Dividend and Approves FY26 Audited Results
Dabur India's Board has approved the audited financial results for the quarter and fiscal year ended March 31, 2026. The company recommended a final dividend of ₹5.50 per equity share (550% of face value), rewarding shareholders for the fiscal year. The statutory auditors provided an unmodified opinion, ensuring the reliability of the reported figures. Additionally, the group reported a minor net loss of ₹1.80 crores from its joint venture operations for the year.
Key Highlights
Recommended a final dividend of ₹5.50 per equity share (550% on face value of ₹1) for FY 2025-26
Statutory auditors issued an unmodified opinion on both standalone and consolidated financial results
Group share of net loss from joint venture reported at ₹1.80 crores for the full year
The 51st Annual General Meeting (AGM) is scheduled for August 06, 2026
Full financial results for FY26 approved and to be published in major newspapers on May 08, 2026
👀 What to Watch
Investors should monitor the upcoming detailed financial statements for volume growth trends and margin performance. The healthy dividend payout confirms the company's commitment to returning capital to shareholders.
Dabur to Incorporate New US Subsidiary Trustline Brands Inc. for FMCG Distribution
Dabur India Limited has announced the incorporation of a new step-down wholly owned subsidiary in Delaware, USA, tentatively named Trustline Brands Inc. The new entity will be formed by Dabur International Limited with an initial cash investment of USD 10,000. This strategic move is intended to enhance the company's FMCG sales and distribution footprint in the United States. The incorporation process is expected to be completed by May 31, 2026.
Key Highlights
Incorporation of Trustline Brands Inc. in Delaware, USA as a step-down wholly owned subsidiary
Initial capital subscription of USD 10,000 divided into 1,000 shares of USD 10 each
100% shareholding to be held by Dabur International Limited
Primary business objective is the sales and distribution of FMCG products in the US market
Target completion date for the incorporation is set for May 31, 2026
👀 What to Watch
This is a strategic expansion move to strengthen international presence; investors should monitor how this entity scales Dabur's US revenue over the coming quarters. The initial investment is nominal, but it establishes a dedicated corporate structure for North American growth.
Dabur Unsecured Creditors Approve Amalgamation with Sesa Care Private Limited
Dabur India Limited held an NCLT-convened meeting for its unsecured creditors on May 02, 2026, to vote on the proposed merger with Sesa Care Private Limited. The meeting, which was initially adjourned for 30 minutes to meet quorum requirements, successfully concluded with the voting process. This amalgamation, part of a process initiated in May 2025, aims to consolidate Sesa Care's operations into Dabur. The submission of the Scrutinizer's report marks a significant procedural milestone in the legal approval timeline for the merger.
Key Highlights
Unsecured creditors meeting held on May 02, 2026, pursuant to NCLT orders dated March 12, 2026.
Proposed Scheme of Amalgamation involves Sesa Care Private Limited (Transferor) and Dabur India Limited (Transferee).
Remote e-voting was conducted between April 28, 2026, and May 01, 2026, followed by e-voting during the meeting.
The meeting achieved the necessary quorum at 01:35 P.M. after a brief 30-minute adjournment.
The Scrutinizer's report dated May 04, 2026, confirms the completion of the voting process for the resolution.
👀 What to Watch
Investors should maintain their positions as the merger moves toward final NCLT approval, which is expected to provide operational synergies in the personal care segment. Monitor for further updates regarding the final effective date of the amalgamation.
Dabur Shareholders Approve Amalgamation with Sesa Care Private Limited
Dabur India Limited has successfully conducted an NCLT-convened meeting on May 02, 2026, to seek shareholder approval for the merger of Sesa Care Private Limited into the company. The voting process, which included remote e-voting from April 28 to May 01, 2026, was overseen by an NCLT-appointed scrutinizer. This amalgamation is being carried out under Sections 230 to 232 of the Companies Act, 2013, aiming to consolidate Sesa Care's business with Dabur. The meeting achieved the required quorum after a brief 30-minute adjournment, marking a key step in the regulatory approval process.
Key Highlights
Shareholders voted on the Scheme of Amalgamation between Sesa Care Private Limited and Dabur India.
Remote e-voting period ran from April 28, 2026 (9:00 AM) to May 01, 2026 (5:00 PM).
The meeting was held via video conferencing on May 02, 2026, following the NCLT order dated March 12, 2026.
The meeting resumed at 11:35 AM after a 30-minute adjournment to meet the requisite quorum.
The resolution covers the amalgamation under Sections 230 to 232 of the Companies Act, 2013.
👀 What to Watch
Investors should view this as a positive step toward corporate consolidation and potential synergy. Monitor for the final NCLT order to confirm the effective date of the merger.
Dabur Concludes Shareholder and Creditor Meetings for Sesa Care Amalgamation
Dabur India Limited conducted NCLT-convened meetings on May 02, 2026, for equity shareholders and unsecured creditors regarding the merger of Sesa Care Private Limited. Both meetings achieved the necessary quorum after a 30-minute adjournment and allowed for electronic voting on the proposed Scheme of Amalgamation. This follows a series of regulatory steps initiated in May 2025 to consolidate Sesa Care's operations into Dabur. The final voting results will determine the next steps in the legal approval process for the merger.
Key Highlights
Meetings held on May 02, 2026, for shareholders (11:00 AM) and unsecured creditors (1:00 PM) via video conferencing.
Remote e-voting was conducted from April 28, 2026, to May 01, 2026, via the NSDL platform.
The merger involves Sesa Care Private Limited as the Transferor and Dabur India as the Transferee Company.
Both meetings were chaired by Dr. Shashank Saksena as appointed by the NCLT New Delhi Bench.
The meetings were successfully concluded at 12:15 PM and 1:43 PM respectively after addressing stakeholder queries.
👀 What to Watch
Investors should watch for the official disclosure of voting results and the subsequent NCLT final order. The integration of Sesa Care is expected to be value-accretive for Dabur's personal care portfolio.
Dabur Concludes Shareholder and Creditor Meetings for Sesa Care Amalgamation
Dabur India Limited conducted NCLT-convened meetings for its equity shareholders and unsecured creditors on May 02, 2026, to approve the Scheme of Amalgamation with Sesa Care Private Limited. The meetings were held via video conferencing following an NCLT order dated March 12, 2026. Remote e-voting was conducted between April 28 and May 01, 2026, with additional voting opportunities provided during the sessions. This merger is part of Dabur's strategic move to consolidate its personal care portfolio.
Key Highlights
Meetings held on May 02, 2026, to approve the merger of Sesa Care Private Limited into Dabur India Limited.
Remote e-voting was open for 4 days from April 28, 2026, to May 01, 2026.
Both the shareholder and creditor meetings were initially adjourned for 30 minutes to meet the requisite quorum.
The proceedings were conducted under the supervision of NCLT-appointed Chairperson Dr. Shashank Saksena.
Final voting results will be declared following the scrutinizer's report on the electronic and meeting-day votes.
👀 What to Watch
Investors should watch for the official announcement of voting results and subsequent NCLT approval to confirm the merger's completion. This consolidation is likely to provide operational synergies in the hair care and personal care segments.
Dabur Appoints Herjit S. Bhalla as CEO of India Business Effective April 23, 2026
Dabur India Limited has officially confirmed the appointment of Mr. Herjit S. Bhalla as the Chief Executive Officer for its India Business, effective from April 23, 2026. This appointment follows a previous management update disclosed on February 17, 2026, and places Mr. Bhalla in a key Senior Management Personnel role. He will report directly to Mr. Mohit Malhotra, the Whole-time Director and Global CEO of the company. This move is intended to streamline leadership within Dabur's largest and most critical market segment.
Key Highlights
Mr. Herjit S. Bhalla joined as CEO - India Business on April 23, 2026.
The appointment follows a prior management change disclosure dated February 17, 2026.
Mr. Bhalla will report to Global CEO Mr. Mohit Malhotra.
The role is classified under the Senior Management Personnel category of the company.
👀 What to Watch
Investors should monitor for any strategic shifts in the domestic FMCG portfolio under the new India CEO. No immediate portfolio changes are recommended as this is a planned leadership transition.
Dabur Q4 FY26 Update: Domestic FMCG to see high-single digit growth; HPC leads with mid-teens growth
Dabur's Q4 FY26 update indicates steady domestic momentum with high-single digit growth in the India FMCG business, though international performance was tempered by Middle East tensions. The Home & Personal Care segment is a standout, expected to grow in the mid-teens, while the Healthcare and F&B verticals faced headwinds from unseasonal rains, resulting in low-single digit growth. Consolidated revenues are projected to grow in the mid-single digits, with operating profits expected to outpace revenue growth, suggesting margin improvement. The company continues to gain market share across key categories like Juices and Hair Oils despite macroeconomic and geopolitical challenges.
Key Highlights
India FMCG business expected to record high-single digit growth with HPC segment growing in mid-teens.
Hair Oils, Shampoo, and Home Care categories likely to record growth in the 20% range.
Consolidated operating profit expected to grow ahead of the mid-single digit topline growth, indicating margin expansion.
International business impacted by Middle East conflict, resulting in low-single digit growth in INR terms despite double-digit CC growth in other markets.
Foods, Real Activ Juices, and Coconut Water maintained strong momentum with 20%+ growth rates.
👀 What to Watch
Investors should focus on the strong domestic recovery and margin expansion as positive indicators for long-term value. While geopolitical risks in the Middle East persist, Dabur's market share gains and growth in the HPC segment provide a solid cushion.
Dabur to Convene Unsecured Creditors Meeting on May 2, 2026 for Sesa Care Merger
Dabur India Limited is moving forward with the amalgamation of Sesa Care Private Limited, a process initiated in May 2025. Following a National Company Law Tribunal (NCLT) order dated March 12, 2026, the company has scheduled a meeting for its unsecured creditors on May 02, 2026. This meeting is a critical regulatory step to obtain approval for the Scheme of Amalgamation. Investors should note that this merger aims to consolidate Dabur's position in the Ayurvedic hair care segment by integrating the Sesa brand.
Key Highlights
NCLT New Delhi Bench issued directions on March 12, 2026, to convene a meeting of unsecured creditors.
The meeting is scheduled for May 02, 2026, at 01:00 P.M. IST via video conferencing.
The scheme involves the merger of Sesa Care Private Limited (Transferor) into Dabur India Limited (Transferee).
This follows a series of regulatory updates regarding the merger dating back to May 26, 2025.
Unsecured creditors will vote on the proposed scheme as per Sections 230 to 232 of the Companies Act, 2013.
👀 What to Watch
No immediate action is required as this is a procedural update in an ongoing merger process. Investors should monitor the outcome of the creditors' meeting and subsequent NCLT final approval for integration timelines.
Dabur to Convene Shareholder Meeting on May 2, 2026, for Sesa Care Amalgamation
Dabur India Limited has scheduled a court-convened meeting of its equity shareholders on May 2, 2026, following directions from the NCLT New Delhi Bench. The primary objective is to seek shareholder approval for the Scheme of Amalgamation between Sesa Care Private Limited and Dabur India. This procedural step follows the initial merger announcement made in May 2025 and subsequent updates. Shareholders will be able to vote on the proposal through remote e-voting or during the virtual meeting.
Key Highlights
Shareholders meeting scheduled for May 02, 2026, at 11:00 AM IST via Video Conferencing.
The meeting is convened as per the NCLT order dated March 12, 2026, under Sections 230-232 of the Companies Act.
The merger involves Sesa Care Private Limited as the Transferor Company and Dabur India as the Transferee Company.
Notice and explanatory statements are being dispatched to shareholders via electronic and physical modes.
This amalgamation process has been in progress since the initial board approval on May 26, 2025.
👀 What to Watch
Investors should review the Scheme of Amalgamation details on Dabur's website to understand the impact on valuation and business synergy. Shareholders are encouraged to participate in the e-voting process to express their stance on the merger.
